Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Living with atopic dermatitis can significantly impact a person's quality of life, characterized by persistent itching, dry skin, and visible inflammation. For many, finding an effective and safe treatment that provides substantial relief is a primary goal. Crisaborole has emerged as a valuable option, offering a new avenue for managing these challenging symptoms. NINGBO INNO PHARMCHEM CO.,LTD. plays a role by ensuring the availability of this critical API.
Patients who have used Crisaborole often report a noticeable reduction in itching and redness, which are hallmark symptoms of atopic dermatitis. The topical application allows for targeted relief directly on the affected skin areas. Unlike some traditional treatments, Crisaborole is a non-steroidal agent, which appeals to patients seeking alternatives to corticosteroids, especially for long-term management where side effects can be a concern. The compound's mechanism of action, inhibiting PDE-4, works to calm the underlying inflammatory processes that fuel the condition.
The ease of use associated with topical treatments is another factor contributing to a positive patient experience. Applying Crisaborole as directed by a healthcare professional can become a routine part of skin management. The ability of Crisaborole to penetrate the skin and exert its anti-inflammatory effects locally helps in breaking the itch-scratch cycle that can exacerbate skin damage and discomfort. This means more comfortable skin, less disrupted sleep, and a generally improved sense of well-being.
For parents managing atopic dermatitis in children, finding treatments that are both effective and safe for younger age groups is particularly important. Crisaborole's indication for patients aged three months and older in the US (and two years and older in the EU) highlights its suitability for pediatric use, providing much-needed relief for young sufferers. The availability of high-quality Crisaborole API, supplied by companies like NINGBO INNO PHARMCHEM CO.,LTD., is fundamental to making these treatments accessible.
Ultimately, the patient experience with Crisaborole is one of hope and tangible improvement. By offering a targeted, non-steroidal approach to managing atopic dermatitis, Crisaborole helps patients regain comfort and confidence in their skin health. NINGBO INNO PHARMCHEM CO.,LTD. is proud to support the pharmaceutical industry in providing these essential treatments by ensuring a consistent supply of premium Crisaborole.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
